Health IT vendor Allscripts has partnered with Elligo Health Research to revamp the way clinical trials are done. Through their alliance, physicians will be able to have a more active say in clinical research. They will be able to conduct such trials in their own clinics and participate as investigators in studies managed by clinical research organizations. Physicians can also glean research revenue, cover trail-related investigator fees and offer new therapies to their patients.
In theory, there shouldn’t be a problem. Patients by and large want to participate in clinical trials – for some their lives depend on it – and drug developers readily need participants to complete their studies on time. Why then, is it so darn hard to recruit for many trials?It’s a complex problem, which not surprisingly has many in the industry looking for a technology-based solution. “The healthcare industry is trying to adopt a whole host of emerging technologies to accelerate and streamline its slow and expensive clinical trial processes,” said Debarati Sengupta, a senior research analyst at Frost & Sullivan, via email.